1189 related articles for article (PubMed ID: 19446658)
1. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
[TBL] [Abstract][Full Text] [Related]
2. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
3. Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch.
Mild M; Esbjörnsson J; Fenyö EM; Medstrand P
J Virol; 2007 Apr; 81(7):3369-76. PubMed ID: 17251288
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia.
Spudich SS; Huang W; Nilsson AC; Petropoulos CJ; Liegler TJ; Whitcomb JM; Price RW
J Infect Dis; 2005 Mar; 191(6):890-8. PubMed ID: 15717264
[TBL] [Abstract][Full Text] [Related]
5. Co-receptor switch during HAART is independent of virological success.
Saracino A; Monno L; Cibelli DC; Punzi G; Brindicci G; Ladisa N; Tartaglia A; Lagioia A; Angarano G
J Med Virol; 2009 Dec; 81(12):2036-44. PubMed ID: 19856465
[TBL] [Abstract][Full Text] [Related]
6. HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use.
Karlsson I; Antonsson L; Shi Y; Karlsson A; Albert J; Leitner T; Olde B; Owman C; Fenyö EM
AIDS; 2003 Dec; 17(18):2561-9. PubMed ID: 14685050
[TBL] [Abstract][Full Text] [Related]
7. Comparison of in vivo and in vitro evolution of CCR5 to CXCR4 coreceptor use of primary human immunodeficiency virus type 1 variants.
Edo-Matas D; van Dort KA; Setiawan LC; Schuitemaker H; Kootstra NA
Virology; 2011 Apr; 412(2):269-77. PubMed ID: 21295814
[TBL] [Abstract][Full Text] [Related]
8. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
Wilkin TJ; Su Z; Kuritzkes DR; Hughes M; Flexner C; Gross R; Coakley E; Greaves W; Godfrey C; Skolnik PR; Timpone J; Rodriguez B; Gulick RM
Clin Infect Dis; 2007 Feb; 44(4):591-5. PubMed ID: 17243065
[TBL] [Abstract][Full Text] [Related]
9. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 co-receptor usage based on V3 loop sequence analysis: preferential suppression of CXCR4 virus post HAART?
Jiao Y; Wang P; Zhang H; Zhang T; Zhang Y; Zhu H; Wu H
Immunol Invest; 2011; 40(6):597-613. PubMed ID: 21513481
[TBL] [Abstract][Full Text] [Related]
11. Genetic characteristics of the V3 region associated with CXCR4 usage in HIV-1 subtype C isolates.
Coetzer M; Cilliers T; Ping LH; Swanstrom R; Morris L
Virology; 2006 Dec 5-20; 356(1-2):95-105. PubMed ID: 16942785
[TBL] [Abstract][Full Text] [Related]
12. Deep Sequencing of the HIV-1 env Gene Reveals Discrete X4 Lineages and Linkage Disequilibrium between X4 and R5 Viruses in the V1/V2 and V3 Variable Regions.
Zhou S; Bednar MM; Sturdevant CB; Hauser BM; Swanstrom R
J Virol; 2016 Aug; 90(16):7142-58. PubMed ID: 27226378
[TBL] [Abstract][Full Text] [Related]
13. The evolution of human immunodeficiency virus type-1 (HIV-1) envelope molecular properties and coreceptor use at all stages of infection in an HIV-1 donor-recipient pair.
Edo-Matas D; Rachinger A; Setiawan LC; Boeser-Nunnink BD; van 't Wout AB; Lemey P; Schuitemaker H
Virology; 2012 Jan; 422(1):70-80. PubMed ID: 22047989
[TBL] [Abstract][Full Text] [Related]
14. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.
Chen Z; Gettie A; Ho DD; Marx PA
Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999
[TBL] [Abstract][Full Text] [Related]
15. Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.
Maeda Y; Takemura T; Chikata T; Kuwata T; Terasawa H; Fujimoto R; Kuse N; Akahoshi T; Murakoshi H; Tran GV; Zhang Y; Pham CH; Pham AHQ; Monde K; Sawa T; Matsushita S; Nguyen TV; Nguyen KV; Hasebe F; Yamashiro T; Takiguchi M
J Virol; 2020 Jun; 94(12):. PubMed ID: 32295903
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
[TBL] [Abstract][Full Text] [Related]
17. [Biological characteristics of HIV-1 isolates circulating in China are linked to its env V3 loop sequence variability].
Hei FX; Hong KX; Song YH; Tang HL; Peng H; Xu JQ; Xing H; Shao YM
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1968-72. PubMed ID: 15730807
[TBL] [Abstract][Full Text] [Related]
18. Emergence, dominance, and possible decline of CXCR4 chemokine receptor usage during the course of HIV infection.
Meehan CJ; Hedge JA; Robertson DL; McCormack GP; Travers SA
J Med Virol; 2010 Dec; 82(12):2004-12. PubMed ID: 20981786
[TBL] [Abstract][Full Text] [Related]
19. N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism.
Ogert RA; Lee MK; Ross W; Buckler-White A; Martin MA; Cho MW
J Virol; 2001 Jul; 75(13):5998-6006. PubMed ID: 11390601
[TBL] [Abstract][Full Text] [Related]
20. Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India.
Cecilia D; Kulkarni SS; Tripathy SP; Gangakhedkar RR; Paranjape RS; Gadkari DA
Virology; 2000 Jun; 271(2):253-8. PubMed ID: 10860879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]